Drug Database
Back to search

Ireland· IE-PA-PA23490/042/001

Sudafed Plus 1 mg/ml + 50 mg/ml nasal spray, solution

A xylometazoline product containing xylometazoline hydrochloride + dexpanthenol, registered in Ireland by JNTL Consumer Health I (Ireland) Limited. The same ATC class is registered in 10 of our 19 countries.

ATC R01AB06

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedSudafed Plus 1 mg/ml + 50 mg/ml nasal…ATCR01AB06REGISTER NO.IE-PA-PA23490/042/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about xylometazoline hydrochloride + dexpanthenolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Xylometazoline is registered in 10 of 19 countries.

Countries holding a registration under ATC R01AB06 (xylometazoline), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose
Search xylometazoline products by name

Xylometazoline · ATC R01AB06

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Xylometazoline hydrochloride + Dexpanthenol
Manufacturer
JNTL Consumer Health I (Ireland) Limited
Country
Ireland (IE)
ATC code
R01AB06
ATC class
Xylometazoline
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA23490/042/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

63 interactions on record for xylometazoline.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check xylometazoline against other medicinesHow interaction checks work

Xylometazoline · interactions on record

63 records

  • 6 severe
  • 54 moderate

Most severe, free to view

  • MethylergometrineG02AB01severe
  • DihydroergotamineN02CA01severe
  • ErgotamineN02CA02severe
  • MethysergideN02CA04severe

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Xylometazoline in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All xylometazoline products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Nasic, Nasic Pur
  • Bulgaria · Nasic назик, Ксилазол
  • Cyprus · Hexarhinal Plus, Hexarhinal Plus Kids
  • Czechia · Nasic, Olynth Plus
  • Germany · Nasenduo Kinder, Nasic
  • Denmark · Zymelin Care
  • Estonia · Otrinazil, Septanazal
  • Spain · Septanasal
  • Finland · Septanazal
  • United Kingdom (Northern Ireland) · Sudafed Plus Blocked Nose
  • Greece · Hexarhinal Plus, Hexarhinal Plus Kids
  • Croatia · Ksilometazolin/Dekspantenol Pliva, Nasic
  • Hungary · Actifed, Actifed Kid
  • Lithuania · Galathenal, Olydex
  • Luxembourg · Nasenduo Nasenspray Kinder, Xyloduo Nasenspray
  • Latvia · Galathenal, Olydex
  • Malta · Septanazal
  • Norway · Xylodex
  • Poland · Nasic, Otrivin Regeneracja
  • Portugal · Nasex Duo, Septanazal Para Adultos
  • Romania · Bixtonim Xylo Duo, Nasic
  • Slovenia · Nasic, Olynth Combo
  • Slovakia · Nasal Duo Active, Nasic

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/201a3fe5-2fc6-4adc-8343-911f320d0aa8
GET /v1/drugs/201a3fe5-2fc6-4adc-8343-911f320d0aa8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nasal spray, solution",
  "routes": [
    "Nasal use"
  ],
  "source": "hpra",
  "atc_all": [
    "R01AB06"
  ],
  "strength": null,
  "pa_number": "PA23490/042/001",
  "substances": [
    "Xylometazoline hydrochloride",
    "Dexpanthenol"
  ],
  "legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "18/10/2024",
  "dispensing_status": "Product not subject to medical prescription",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about xylometazoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console